ODDB.org: Open Drug Database

Pfizer AG - Zirabev 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	67501	Sequence	02
Product name	Zirabev 400 mg/16 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FG01	ATC-Description
Introduction of Sequence	10.05.2020

Composition

bevacizumabum 400 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 9.29 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	400mg / 16ml

BAG: Active Agent	Dose
Bevacizumab	400 mg

Inactive agents
Succinic Acid
Dinatrii Edetas
Sodium Hydroxide
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		962.84	1063.55	A	SL	Yes

2025	©ywesee GmbH